The study found the brains of those who had Covid-19 had a greater loss of grey matter and abnormalities in the brain tissue compared with those who didn't have Covid-19. Many of those changes were in the area of the brain related to the sense of smell.
Patients with even a mild case of Covid-19 may experience accelerated aging of the brain and other changes to it, according to a new study.
The study, published Monday in the journal Nature, is believed to be the largest of its kind. It found that the brains of those who had Covid-19 had a greater loss of grey matter and abnormalities in the brain tissue compared with those who didn't have Covid-19. Many of those changes were in the area of the brain related to the sense of smell.
Isaacson said the study findings were noticeable for clinicians, but he added that the overall impact on individuals was difficult to determine and could be small."It's really hard to know the long-term clinical impact and quality of life impact in a situation like this," he said. "The brain may be affected by other mechanisms such as immune, inflammatory, vascular or psychological/behavioral change but not direct infection," said Dr.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Four Covid-related deaths and 1,725 casesThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,230.
Read more »
How COVID-19 continues to impact birthing practices
Read more »
Big Cities Drop More COVID-19 Measures in Push for NormalcyNew York City, which has long prided itself as having the nation’s toughest COVID-19 safety protocols, will do away with several of its mandates next week, including required masking in public schools and vaccination requirements at restaurants, entertainment and cultural venues, the mayor announced Friday.
Read more »
High demand for drug to prevent COVID-19 in the vulnerable, yet doses go unusedHigh Demand for Drug to Prevent COVID-19 in the Vulnerable, Yet Doses Go Unused
Read more »
Novavax’s Covid-19 Vaccine Moves Closer to FDA Authorization DecisionNovavax says it has resolved the manufacturing problems that delayed U.S. authorization of its Covid-19 vaccine. Health regulators have begun their review.
Read more »